Export 2652 results:
Author Title Type [ Year(Desc)]
S. Morgello, Cortes, E. P., Gensler, G., Meloni, G., Jacobs, M. M., Murray, J., Borukov, V., and Crary, J. F., HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition., AIDS, 2021.
S. E. Frey, Stapleton, J. T., Ballas, Z. K., Rasmussen, W. L., Kaufman, T. M., Blevins, T., Jensen, T. L., D Davies, H., Tary-Lehman, M., Chaplin, P., Hill, H., and Goll, J. B., Human antibody responses following vaccinia immunization using protein microarrays and correlation with cell-mediated and antibody dependent cellular cytotoxicity responses., J Infect Dis, 2021.
S. Sivapalasingam, Saviolakis, G. A., Kulcsar, K., Nakamura, A., Conrad, T., Hassanein, M., Sumner, G., Elango, C., Kamal, M. A., Eng, S., Kyratsous, C. A., Musser, B. J., Frieman, M., Kantrowitz, J., Weinreich, D. M., Yancopoulos, G., Stahl, N., and Lipsich, L., Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)., J Infect Dis, 2021.
P. Winokur, Sahly, H. M. El, Mulligan, M. J., Frey, S. E., Rupp, R., Anderson, E. J., Edwards, K. M., Bernstein, D. I., Schmader, K., Jackson, L. A., Chen, W. H., Hill, H., and Bellamy, A., Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older., Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
M. Shahait, Liu, V. Y. T., Vapiwala, N., Lal, P., Kim, J., Trabulsi, E. J., Huang, H. - C., Davicioni, E., Thompson, D. J. S., Spratt, D., Den, R. B., and Lee, D. I., Impact of Decipher on use of post-operative radiotherapy: Individual patient analysis of two prospective registries., BJUI Compass, 2021.
M. E. Horwitz, tiff, P., Rezvani, A. R., Hwang, W. Ying Khee, Karras, N., Valcarcel, D., Koh, L. Piu, yasser, K., Keating, A. K., Segalovich, I., Sanz, G., Cutler, C., Brunstein, C. G., Hanna, R., McGuirk, J. P., Lindemans, C. A., Maziarz, R. T., Schiller, G. J., Hammerschlak, N., Frankfurt, O., Blackwell, B., and Galamidi, E., Improved Clinical Outcomes with Omidubicel versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized, Multicenter Study. 2021.
R. Kondapaka, Vijayarangan, A., Henning, A., Kunwar, P., and Schlessman, K., Leveraging patient profiles for routine pharmacovigilance in clinical trials, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
D. A. J. Friedman-Klabanoff, Berry, A. A., Travassos, M. A., Cox, C., Zhou, Y., Mo, A. X., Nomicos, E. Y. H., Deye, G. A., Pasetti, M. F., and Laurens, M. B., Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing., Vaccine, vol. S0264-410X(20)31590, 2021.
A. M. Denicoff, S. Ivy, P., Worthington, K. H., Zhao, J., Seibel, N., Mishkin, G. E., Mooney, M. M., and Little, R. F., National Cancer Institute (NCI) implementation of the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) broadening clinical trials eligibility criteria, ASCO Annual Meeting 2021. 2021.
A. A. Pietraszkiewicz, Payne, D., Abraham, M., Garced, A., Devarasetty, K. C., Wall, M., Menezes, S. M., Ugarte, S., Pirsl, F., Goklemez, S., Ferris, F. L., Barrett, J., Battiwalla, M., Childs, R. W., Pavletic, S. Z., and Bishop, R. J., Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study., Bone Marrow Transplant, 2021.
S. R. Morris, Bristow, C. C., Wierzbicki, M. R., Sarno, M., Asbel, L., French, A., Gaydos, C. A., Hazan, L., Mena, L., Madhivanan, P., Philip, S., Schwartz, S., Brown, C., Styers, D., Waymer, T., and Klausner, J. D., Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study., Lancet Infect Dis, vol. 21, no. 5, pp. 668-676, 2021.
S. C. Murphy, Deye, G. A., B Sim, K. Lee, Galbiati, S., Kennedy, J. K., Cohen, K. W., Chakravarty, S., Kc, N., Abebe, Y., James, E. R., Kublin, J. G., Hoffman, S. L., Richie, T. L., and Jackson, L. A., PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection., PLoS Pathog, vol. 17, no. 5, p. e1009594, 2021.
T. P. Lodise, Van Wart, S., Sund, Z. M., Bressler, A. M., Khan, A., Makley, A. T., Hamad, Y., Salata, R. A., Silveira, F. P., Sims, M. D., Kabchi, B. A., Saad, M. A., Brown, C., Oler, R. E., Fowler, V., and Wunderink, R. G., Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN)., Antimicrob Agents Chemother, vol. 65, no. 3, 2021.
C. I. Campbell, Saxon, A. J., Boudreau, D. M., Wartko, P. D., Bobb, J. F., Lee, A. K., Matthews, A. G., McCormack, J., Liu, D. S., Addis, M., Altschuler, A., Samet, J. H., LaBelle, C. T., Arnsten, J., Caldeiro, R. M., Borst, D. T., Stotts, A. L., Braciszewski, J. M., Szapocznik, J., Bart, G., Schwartz, R. P., McNeely, J., Liebschutz, J. M., Tsui, J. I., Merrill, J. O., Glass, J. E., Lapham, G. T., Murphy, S. M., Weinstein, Z. M., Yarborough, B. Jo H., and Bradley, K. A., PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment., Addict Sci Clin Pract, vol. 16, no. 1, p. 9, 2021.
A. G. Callahan, Coleman-Cowger, V. H., Schulkin, J., and Power, M. L., Racial disparities in influenza immunization during pregnancy in the United States: A narrative review of the evidence for disparities and potential interventions., Vaccine, vol. 39, no. 35, pp. 4938-4948, 2021.
K. Page, Melia, M. T., Veenhuis, R. T., Winter, M., Rousseau, K. E., Massaccesi, G., Osburn, W. O., Forman, M., Thomas, E., Thornton, K., Wagner, K., Vassilev, V., Lin, L., Lum, P. J., Giudice, L. C., Stein, E., Asher, A., Chang, S., Gorman, R., Ghany, M. G., T Liang, J., Wierzbicki, M. R., Scarselli, E., Nicosia, A., Folgori, A., Capone, S., and Cox, A. L., Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection., N Engl J Med, vol. 384, no. 6, pp. 541-549, 2021.
S. Whittier, Au, A., Sarraf, D., Oden, N., VanVeldhuisen, P., Scott, I., Ip, M., Watson, S., Blodi, B., and Domalpally, A., Reproducibility of Grading Superficial vs Deep Retinal Hemorrhage in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2), in Association for Research in Vision and Ophthalmology Annual Meeting, 2021.
L. Revoredo, Salazar, D., Case, A., and Hart, B., Responsible Tracking and Accounting of Participant Mental Health Urgency/Emergency Responses in Substance Use Treatment Clinical Trials, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
L. Revoredo, Salazar, D., Case, A., and Hart, B., Responsible Tracking and Accounting of Participant Mental Health Urgency/Emergency Responses in Substance Use Treatment Clinical Trials, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
T. D. L. Keenan, Clemons, T. E., Domalpally, A., Elman, M. J., Havilio, M., Agrón, E., Benyamini, G., and Chew, E. Y., Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study., Ophthalmology, vol. 128, no. 1, pp. 100-109, 2021.
F. Scaggs Huang, Bernstein, D. I., Slobod, K. S., Portner, A., Takimoto, T., Russell, C. J., Meagher, M., Jones, B. G., Sealy, R. E., Coleclough, C., Branum, K., Dickey, M., Buschle, K., McNeal, M., Makowski, M., Nakamura, A., and Hurwitz, J. L., Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults., Hum Vaccin Immunother, vol. 17, no. 2, pp. 554-559, 2021.
E. V. Millar, Bennett, J. W., Barin, B., Carey, P. M., Law, N. N., English, C. E., Schwartz, M. M., Cochrane, T., Ellis, M. W., Tribble, D. R., M Cooke, T., and Hennessey, J. P., Safety, Immunogenicity, And Efficacy Of Ndv-3a Against Staphylococcus Aureus Colonization: A Phase 2 Vaccine Trial Among Us Army Infantry Trainees, Vaccine, vol. 39, no. 23, pp. 3179-3188, 2021.
H. M. El Sahly, Atmar, R. L., Sendra, E., Wegel, A., and Keitel, W. A., Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults., J Infect Dis, vol. Online Ahead of Print, 2021.
L. Revoredo, Lewis, M., Shmueli-Blumberg, D., and Jelstrom, E., Transitioning to the Remote Collection of Urine Specimens for Urine Drug Screening During COVID-19., in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
S. M. Tolaney, Garrett-Mayer, E., White, J., Blinder, V. S., Foster, J. C., Amiri-Kordestani, L., E Hwang, S., Bliss, J. M., Rakovitch, E., Perlmutter, J., Spears, P. A., Frank, E., Tung, N. M., Elias, A. D., Cameron, D., Denduluri, N., Best, A. F., DiLeo, A., Baizer, L., Butler, L. Pearson, Schwartz, E., Winer, E. P., and Korde, L. A., Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0., J Clin Oncol, p. JCO2003613, 2021.